ScholarIQanswers from OpenAlex & ORCID
Katherine A. High
ResearcherPublications, citations & collaboration network
Katherine A. High is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Katherine A. High have?
ScholarIQindexed works
Katherine A. High has 376 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Katherine A. High have?
ScholarIQcitation count
Katherine A. High has 40,139 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Katherine A. High?
ScholarIQh-index
Katherine A. High has an h-index of 92 in OpenAlex.
What is the i10-index of Katherine A. High?
ScholarIQi10-index
Katherine A. High has an i10-index of 219 in OpenAlex.
What is the ORCID of Katherine A. High?
ScholarIQorcid
The ORCID for Katherine A. High is on the source record.
What is the OpenAlex record for Katherine A. High?
ScholarIQopenalex
The OpenAlex for Katherine A. High is on the source record.
What are the most-cited papers on Katherine A. High?
ScholarIQmost cited works
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda, Bertil Glader, Margaret V. Ragni, John E.J. Rasko, Margareth C. Ozelo, Keith Hoots, Philip M. Blatt, Barbara A. Konkle, Michael D. Dake, Robin Kaye, Mahmood Razavi, Albert Zajko, James L. Zehnder, Pradip K. Rustagi, Hiroyuki Nakai, Amy Chew, Debra G. B. Leonard, J Fraser Wright, Ruth Lessard, Jürg M. Sommer, Michael Tigges, Denise E. Sabatino, Alvin Luk, Haiyan Jiang, Federico Mingozzi, Linda Couto, Hildegund C.J. Ertl, Katherine A. High, Mark A. Kay
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Sarah McCague, Dominique Cross, Kathleen Marshall, Jean Walshire, Taylor Kehoe, Hannah Reichert, Maria Davis, Leslie Raffini, Lindsey A. George, Fleur Hudson, Laura Dingfield, Xiaosong Zhu, Julia A. Haller, Elliott H. Sohn, Vinit B. Mahajan, Wanda Pfeifer, Michelle T. Weckmann, Chris A. Johnson, Dina Y. Gewaily, Arlene V. Drack, Edwin M. Stone, Katie Wachtel, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Albert M. Maguire
Gene therapy comes of age
Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Donald B. Kohn, Keiya Ozawa, Michel Sadelain
Assessing the potential for AAV vector genotoxicity in a murine model
Hojun Li, Nirav Malani, Shari R Hamilton, Alexander Schlachterman, Giulio Bussadori, Shyrie E. Edmonson, Rachel Shah, Valder R. Arruda, Federico Mingozzi, J. Fraser Wright, Frederic D. Bushman, Katherine A. High